Hormone treatments commonly used by menopausal women appear to accelerate brain shrinkage, according to two new studies released
The research showed that memory loss was most pronounced in women who already had some form of it is important to note and in the medical journal Neurology, showed greater than typical brain tissue loss in women 65 and older. Previous studies showed that older women on progestin-based drugs had decreased thinking skills and memory, and were more likely to suffer from dementia and brain diminished function.
Doctors long had believed that the impairment had been caused by tiny vascular brain lesions caused by hormonal treatments. But the new research using MRI scans of women's brains appears to show a reduction in brain tissue in regions critical to memory for women who used the hormones.
"Our findings suggest one possible explanation for the increased risk for dementia in older women who had previously taken post-menopausal hormone therapy," said Laura Coker of Wake Forest University Baptist Medical Centre, a lead researcher on one of the studies.
HRT has negative affect on brain structures
A second study found that women who had taken hormone therapy had slightly smaller brain volumes in the brain's frontal lobe and the hippocampus - both critical areas for thinking and memory skills. "Our findings suggest that hormone therapy in older post-menopausal women has a negative effect on brain structures important in
maintaining normal memory functioning," the study concluded.
"However, this negative effect was most pronounced in women who
already may have had some memory problems before using hormone
therapy," the research found.
The study tracked more than 1 400 women, ages 71 to 89, who had
previously participated in a hormone therapy study for between an
average of four to six years. The findings suggest that hormone therapy to treat the symptoms of menopause should be used only when deemed absolutely necessary, and
then at the lowest dose and for the shortest possible time. – (Sapa, January 2009)
New study links HRT, cancer
HRT doubles breast cancer risk